Two Big Names Buck Today’s Market Trend… Plus More Bruises For Boeing 8/20/24

CNBC's "Fast Money"

CNBC

Business, Investing, News

4.3 • 1.2K Ratings

🗓️ 20 August 2024

⏱️ 44 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The market rally stalling out, but that didn’t stop Netflix and Eli Lilly from hitting fresh all-time highs. Why the streamer and pharma stock jumped, and if there’s more gains in store. Plus Boeing losing altitude yet again… as the plane maker pauses testing of one of its fleets. And with new CEO Robert Kelly Ortberg at the helm, how will the company handle the latest setback? Fast Money Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0	Thank you very much John Fort live from the NASDAQ market site right in the heart of New York City's Times Square.
0:05.8	This is fast money and here's what's on tap for tonight.
0:09.0	Eight is enough.
0:11.0	No, not the 70s TV show, the 8 day winning streak for the S&P in
0:15.1	NASDAQ is over. So does this mean the rebound rally has run out of steam?
0:20.3	We'll debate that. Plus, blockbuster results, new data from Eli Lilly showing its
0:25.1	popular weight loss drug reduces type 2 diabetes risks by over 90 percent. The impact
0:32.2	across the health care sector straight ahead and then later on
0:34.8	Boeing's new wide body headache charting the next move in commodities and
0:39.0	Bank of America's new Berkshire Blues. I'm Dominic Chu in for Melissa Lee tonight here in
0:44.2	Studio B at the NASDAQ market site on the desk, Tim Seymour, Dan
0:49.8	Nathan, Guy Adami, and Katie Stockton, managing partner of Fair Lead Strategies.
0:55.8	We're going to begin with stocks cooling off from the recent rally, the S&P 500,
0:59.3	NASDAQ each snapping their eight-day winning streaks streaks as you can see there.
1:03.6	Still two of the years big winners managed to buck today's breather and
1:07.7	ripped to all-time highs.
1:09.6	Netflix jumping a percent and a half on positive news for its ad business.
1:13.5	We got more in that story in just a moment.
1:15.8	And Eli Lilly, surging 3 percent after a long-term study showed its weight loss
1:20.6	drugs zep-bound slash the risk of type 2 diabetes by a whopping 94%.
1:28.1	The news hit diabetes and obesity device makers.
1:31.3	Think names like Dexcom, Insulate, Abbott Labs, all falling sharply lower.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.